摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-chloro-1-[4-(1,1-dimethyl-2-oxo-2-pyrrolidin-1-yl-ethyl)-phenyl]-butan-1-one | 169280-18-6

中文名称
——
中文别名
——
英文名称
4-chloro-1-[4-(1,1-dimethyl-2-oxo-2-pyrrolidin-1-yl-ethyl)-phenyl]-butan-1-one
英文别名
2-[4-(4-Chloro-butyryl)-phenyl]-2-methyl-propionic acid , pirrolidineamide;2-[4-(4-chloro-butyryl)-phenyl]-2-methyl-propionic acid, pyrrolidineamide;2-[4-(4-Chlorobutanoyl)phenyl]-2-methyl-1-pyrrolidin-1-ylpropan-1-one
4-chloro-1-[4-(1,1-dimethyl-2-oxo-2-pyrrolidin-1-yl-ethyl)-phenyl]-butan-1-one化学式
CAS
169280-18-6
化学式
C18H24ClNO2
mdl
——
分子量
321.847
InChiKey
RVCOUNUUGHTLTA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-chloro-1-[4-(1,1-dimethyl-2-oxo-2-pyrrolidin-1-yl-ethyl)-phenyl]-butan-1-one 在 sodium tetrahydroborate 、 乙醇三乙胺 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 生成 2-(4-{1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl}phenyl)-2-methyl-1-(pyrrolidin-1-yl)propan-1-one
    参考文献:
    名称:
    盐酸非索非那定的合成方法
    摘要:
    本发明公开了盐酸非索非那定的合成方法,本发明的盐酸非索非那定的合成方法以2‑(4‑溴苯基)‑2‑甲基丙酸(2)为原料,将其与四氢吡咯反应保护羧基,再与γ‑丁内酯反应,生成化合物6,化合物6与对甲苯磺酰氯反应,产物再与α,α‑二苯基‑4‑哌啶甲醇缩合,后经还原,脱保护,最终制得目标化合物1。此路线所用原料价廉易得,反应条件温和,操作简捷,对环境污染较小,是一条具有较好应用前景的工业化路线。
    公开号:
    CN104876853B
  • 作为产物:
    描述:
    2-methyl-2-phenyl-1-(pyrrolidin-1-yl)propan-1-one4-氯丁酰氯三氯化铝 作用下, 以 四氯化碳 为溶剂, 反应 17.0h, 以78%的产率得到4-chloro-1-[4-(1,1-dimethyl-2-oxo-2-pyrrolidin-1-yl-ethyl)-phenyl]-butan-1-one
    参考文献:
    名称:
    Intermediates useful for the preparation of antihistaminic piperidine derivatives
    摘要:
    本发明涉及一种新型中间体和工艺,用于制备某些抗组胺哌啶衍生物,其化学式为 其中 W代表—C(═O)—或—CH(OH)—; R1代表氢或羟基; R2代表氢; R1和R2一起形成连接R1和R2所带的碳原子之间的第二键; n为1至5的整数; m为0或1的整数; R3为—COOH或—COO烷基,其中烷基部分具有1至6个碳原子,直链或支链,A的每个是氢或羟基; 以及其药学上可接受的盐和各自的光学异构体,但其中R1和R2一起形成连接R1和R2所带的碳原子之间的第二键,或者R1代表羟基时,m为整数0。
    公开号:
    US06340761B1
点击查看最新优质反应信息

文献信息

  • Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
    申请人:Aventisub II Inc.
    公开号:EP2261208A1
    公开(公告)日:2010-12-15
    The present invention is related to novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of formula (I) wherein W represents -C(=O)- or -CH(OH)-; R1 represents hydrogen or hydroxy; R2 represents hydrogen; R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; m is an integer 0 or 1; R3 is -COOH or -COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.
    本发明涉及一种新型中间体和制备某些抗组胺哌啶衍生物的方法,其化学式为(I),其中W代表-C(=O)-或-CH(OH)-;R1代表氢或羟基;R2代表氢;R1和R2一起形成连接带有R1和R2的碳原子之间的第二个键;n为1至5的整数;m为0或1的整数;R3为-COOH或-COOalkyl,其中烷基具有1至6个碳原子,是直链或支链;每个A是氢或羟基;以及其药学上可接受的盐和单一光学异构体,但当R1和R2一起形成连接带有R1和R2的碳原子之间的第二个键或当R1代表羟基时,m为0。
  • Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
    申请人:Aventis Inc.
    公开号:EP1953142A1
    公开(公告)日:2008-08-06
    The present invention is related to novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of formula (I) wherein W represents -C(=O)- or -CH(OH)-; R1 represents hydrogen or hydroxy; R2 represents hydrogen; R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; m is an integer 0 or 1; R3 is -COOH or -COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.
    本发明涉及一种新的中间体和过程,可用于制备某些抗组胺哌啶衍生物,该衍生物的化学式为(I),其中W代表-C(=O)-或-CH(OH)-; R1代表氢或羟基; R2代表氢; R1和R2在承载R1和R2的碳原子之间形成第二个键; n是1到5的整数; m是0或1的整数; R3是-COOH或-COOalkyl,其中烷基具有1到6个碳原子,且为直链或支链; A的每个代表氢或羟基; 以及其药学上可接受的盐和单一光学异构体,但其中当R1和R2在承载R1和R2的碳原子之间形成第二个键或R1代表羟基时,m为0。
  • Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
    申请人:Merrell Pharmaceuticals Inc.
    公开号:US20010018521A1
    公开(公告)日:2001-08-30
    The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1 wherein W represents —C(═O)— or —CH(OH)—; R 1 represents hydrogen or hydroxy; R 2 represents hydrogen; R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 ; n is an integer of from 1 to 5; m is an integer 0 or 1; R 3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R 1 and R 2 are ta′ to form a second bond between the carbon and R 1 and R 2 or where R 1 represented hydroxy integer 0.
    本发明涉及一种新型中间体和过程,其在制备某些抗组胺哌啶衍生物的过程中有用,该衍生物的化学式为1,其中W代表—C(═O)—或—CH(OH)—;R1代表氢或羟基;R2代表氢;R1和R2一起形成连接R1和R2的碳原子之间的第二个键;n为1至5的整数;m为0或1的整数;R3为—COOH或—COO烷基,其中烷基部分具有1至6个碳原子,是直链或支链;每个A都是氢或羟基;以及其药学上可接受的盐和各自的光学异构体,但其中当R1和R2结合形成连接R1和R2的第二个键时,或当R1代表羟基时,n为0。
  • NOVEL INTERMEDIATES FOR THE PREPARATION OF ANTIHISTAMINIC 4-DIPHENYLMETHYL/DIPHENYLMETHOXY PIPERIDINE DERIVATIVES
    申请人:MERRELL PHARMACEUTICALS INC.
    公开号:EP0705245A1
    公开(公告)日:1996-04-10
  • US6147216A
    申请人:——
    公开号:US6147216A
    公开(公告)日:2000-11-14
查看更多